Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 94.00 | |
5 mg | In stock | $ 233.00 | |
10 mg | In stock | $ 326.00 | |
25 mg | In stock | $ 478.00 | |
50 mg | In stock | $ 688.00 | |
100 mg | In stock | $ 987.00 | |
500 mg | In stock | $ 1,980.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 219.00 |
Description | Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2. |
Targets&IC50 | JAK2:0.72 nM, JAK1:33 nM, TYK2:22 nM, JAK3:39 nM |
In vitro | Ilginatinib hydrochloride(NS-018 hydrochloride) is highly active against JAK2 with a 50% inhibition (IC(50)) of <1 n, and had 30-50-fold greater selectivity for JAK2 over other JAK-family kinases, such as JAK1, JAK3 and tyrosine kinase 2. In addition to JAK2, NS-018 inhibited Src-family kinases. NS-018 showed potent antiproliferative activity against cell lines expressing a constitutively activated JAK2 (the JAK2V617F or MPLW515L mutations or the TEL-JAK2 fusion gene; IC(50)=11-120 n), but showed only minimal cytotoxicity against most other hematopoietic cell lines without a constitutively activated JAK2[1]. |
In vivo | Ilginatinib hydrochloride(NS-018 hydrochloride) preferentially suppressed in vitro erythropoietin-independent endogenous colony formation from polycythemia vera patients.NS-018 also markedly reduced splenomegaly and prolonged the survival of mice inoculated with Ba/F3 cells harboring JAK2V617F.In addition, NS-018 significantly reduced leukocytosis, hepatosplenomegaly and extramedullary hematopoiesis, improved nutritional status, and prolonged survival in JAK2V617F transgenic mice.suggest that NS-018 will be a promising candidate for the treatment of MPNs[1]. |
Synonyms | NS-018 hydrochloride |
Molecular Weight | 425.89 |
Formula | C21H21ClFN7 |
CAS No. | 1239358-85-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 2 mg/mL (4.70 mM), Sonication is recommended.
DMSO: 35 mg/mL (82.18 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ilginatinib hydrochloride 1239358-85-0 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors JAK Tyrosine Kinases Tyk2 Ilginatinib JAK1 NS 018 Hydrochloride JAK2 Inhibitor NS018 Hydrochloride bioavailable NS018 NS-018 Hydrochloride NS-018 orally inhibit Janus kinase JAK3 NS 018 Ilginatinib Hydrochloride NS-018 hydrochloride inhibitor